Originally published December 1 2005
Japan reports 12 childrens' deaths linked to Tamiflu
by Mike Adams, the Health Ranger, NaturalNews Editor
The FDA will hold an advisory panel meeting in response to Japanese medical reports that have found Tamiflu was linked to 12 children's deaths and a range of side effects, including hallucinations.
The U.S. Food and Drug Administration also said it was "concerning" that 32 psychiatric events, such as hallucinations and abnormal behavior, had been reported in children who took Tamiflu, which is in high demand because it is considered to be one of the best defenses against avian flu in people.
Most of the reports came from Japan, the FDA said.
The agency's summary was posted on its own Web site.
In a separate summary on the FDA site, Roche said: "There is no increase in deaths and neuropsychiatric events in patients on Tamiflu versus influenza patients in general."
Officials from the FDA and Roche will present information about the cases to a meeting of an FDA advisory panel Friday.
Roche shares were trading 2.6 percent lower at 187 Swiss francs in Zurich.
Gilead Sciences Inc. (Research), which invented the drug and receives royalties on Tamiflu sales, fell three percent to $53.94 in morning Nasdaq trade.
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml